In adults, GLP-1 RAs were associated with weight loss in patients with overweight or obesity with and without type 2 diabetes, as well as reduction in adverse cardiovascular outcomes and reduced progression of diabetes-related nephropathy (21–26). This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.